drugset / Trial / NCT01373983

Intrathecal Bolus Doses of Ziconotide

NCT01373983 ↗

Phase 4 Completed 26 enrolled University Hospital, Linkoeping
NaSingle-groupOpen-label

Summary

The purpose of this study is to evaluate if the effect of ziconotide can be tested by intrathecal bolus doses.

Timeline

Start
2011-08
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Ziconotide Unknown 1.25 ug Intrathecal
Subject Ziconotide Unknown 2.5 ug Intrathecal
Subject Ziconotide Unknown 3.75 ug Intrathecal

Indications